BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9051936)

  • 1. Pharmacology of anthelmintic resistance.
    Sangster N
    Parasitology; 1996; 113 Suppl():S201-16. PubMed ID: 9051936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthelmintic drug actions in resistant and susceptible C. elegans revealed by electrophysiological recordings in a multichannel microfluidic device.
    Weeks JC; Robinson KJ; Lockery SR; Roberts WM
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):607-628. PubMed ID: 30503202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
    Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C
    PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthelmintic resistance: past, present and future.
    Sangster NC
    Int J Parasitol; 1999 Jan; 29(1):115-24; discussion 137-8. PubMed ID: 10048824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthelmintic resistance.
    Prichard R
    Vet Parasitol; 1994 Aug; 54(1-3):259-68. PubMed ID: 7846855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modes of action of anthelmintic drugs.
    Martin RJ
    Vet J; 1997 Jul; 154(1):11-34. PubMed ID: 9265850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Field studies investigating anthelmintic resistance in young cattle on five farms in New Zealand.
    Mason PC; McKay CH
    N Z Vet J; 2006 Dec; 54(6):318-22. PubMed ID: 17151731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of levamisole and pyrantel, anthelmintic resistance, E153 and Q57.
    Martin RJ; Robertson AP
    Parasitology; 2007; 134(Pt 8):1093-104. PubMed ID: 17608969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical basis of anthelmintic action and resistance.
    Köhler P
    Int J Parasitol; 2001 Apr; 31(4):336-45. PubMed ID: 11400692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of nematode parasites with agents acting on neuro-musculature systems: lessons for neuropeptide ligand discovery.
    Martin RJ; Robertson AP
    Adv Exp Med Biol; 2010; 692():138-54. PubMed ID: 21189677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoproteins play a role in ivermectin resistance in cyathostomins.
    Peachey LE; Pinchbeck GL; Matthews JB; Burden FA; Lespine A; von Samson-Himmelstjerna G; Krücken J; Hodgkinson JE
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):388-398. PubMed ID: 29121562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.
    Kaewintajuk K; Cho PY; Kim SY; Lee ES; Lee HK; Choi EB; Park H
    Parasitol Res; 2010 Jun; 107(1):27-30. PubMed ID: 20309581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic landscape of drug response reveals mediators of anthelmintic resistance.
    Doyle SR; Laing R; Bartley D; Morrison A; Holroyd N; Maitland K; Antonopoulos A; Chaudhry U; Flis I; Howell S; McIntyre J; Gilleard JS; Tait A; Mable B; Kaplan R; Sargison N; Britton C; Berriman M; Devaney E; Cotton JA
    Cell Rep; 2022 Oct; 41(3):111522. PubMed ID: 36261007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the mode of action of anthelmintic drugs: tools to investigate the biochemical peculiarities of helminths.
    Vanden Bossche H
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():99-102. PubMed ID: 2264693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance as a tool for discovering and understanding targets in parasite neuromusculature.
    Sangster NC; Song J; Demeler J
    Parasitology; 2005; 131 Suppl():S179-90. PubMed ID: 16569289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular aspects of drug resistance in parasitic helminths.
    Roos MH; Kwa MS; Veenstra JG; Kooyman FN; Boersema JH
    Pharmacol Ther; 1993 Nov; 60(2):331-6. PubMed ID: 8022863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide Approaches to Investigate Anthelmintic Resistance.
    Doyle SR; Cotton JA
    Trends Parasitol; 2019 Apr; 35(4):289-301. PubMed ID: 30733094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action.
    Harder A; Schmitt-Wrede HP; Krücken J; Marinovski P; Wunderlich F; Willson J; Amliwala K; Holden-Dye L; Walker R
    Int J Antimicrob Agents; 2003 Sep; 22(3):318-31. PubMed ID: 13678839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein in helminths: function and perspectives for anthelmintic treatment and reversal of resistance.
    Kerboeuf D; Blackhall W; Kaminsky R; von Samson-Himmelstjerna G
    Int J Antimicrob Agents; 2003 Sep; 22(3):332-46. PubMed ID: 13678840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of third generation P-glycoprotein inhibitors on the sensitivity of drug-resistant and -susceptible isolates of Haemonchus contortus to anthelmintics in vitro.
    Raza A; Kopp SR; Jabbar A; Kotze AC
    Vet Parasitol; 2015 Jun; 211(1-2):80-8. PubMed ID: 25986327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.